Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of dutasteride at reducing
relapse rates of Acute Urinary Retention (AUR), including reduction in surgical intervention
for benign prostatic hyperplasia (BPH), in patients who receive a 6 month treatment of
dutasteride (0.5mg once daily) following a single episode of AUR followed by successful Trial
Without Catheter compared with placebo.